Bellicum pharmaceuticals announces aggregate gross proceeds of $69.6 million from $139.6 million public offering and private placement

Closing of $57.5 million public offering of preferred stock and warrants and receipt of $12.1 million option fee related to private placement of up to $70.0 million of preferred stock and warrants  closing of $57.5 million public offering of preferred stock and warrants and receipt of $12.1 million option fee related to private placement of up to $70.0 million of preferred stock and warrants
BLCM Ratings Summary
BLCM Quant Ranking